Literature DB >> 25757955

Concurrent angiomyolipomas and renal cell neoplasms in patients without tuberous sclerosis: a retrospective study.

Mariachiara Mei1, Lauren E Rosen2, Vijaya Reddy3, David J Cimbaluk3, Paolo Gattuso3.   

Abstract

Synchronous renal cell neoplasms (RCNs) and angiomyolipomas (AML) occurring in the same kidney are rare. The aim of this retrospective study is to investigate the incidence and clinicopathological features of concurrent AML and RCN in patients without tuberous sclerosis complex (TSC). Partial and radical nephrectomy specimens with a diagnosis of RCN and AML from 1995 to May 2013 were reviewed. Cases were assessed for histological subtype of AML and RCN, topographic relationship between the AML and the RCN, and clinical characteristics. A total of 565 RCNs and 19 AMLs were identified. Of 19 cases of AML, 9 (47%) were associated with renal tumors. Clear-cell renal cell carcinoma (RCC) was the most common malignancy associated with AML (56%). The mean age of patients with concomitant AML and RCN was higher than the mean age of patients with only AML (58.6 vs 55.5 years). The majority of patients with concomitant AML and RCN were female (78%). All concurrent sporadic AMLs were benign. We identified one case of bilateral clear-cell RCC with concomitant multiple bilateral AMLs in a patient with TSC.
© The Author(s) 2015.

Entities:  

Keywords:  angiomyolipoma; concomitant renal neoplasm; renal cell neoplasms

Mesh:

Year:  2015        PMID: 25757955     DOI: 10.1177/1066896915569914

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  Multiple angiomyolipomas mimicking metastases of concurrent clear cell renal cell carcinoma.

Authors:  Takahiro Narimatsu; Toshitaka Shin; Tadamasa Shibuya; Toru Inoue; Kenichi Hirai; Tadasuke Ando; Fuminori Sato; Tsutomu Daa; Hiromitsu Mimata
Journal:  IJU Case Rep       Date:  2019-03-31

Review 2.  The Risks of Renal Angiomyolipoma: Reviewing the Evidence.

Authors:  Raouf M Seyam; Waleed K Alkhudair; Said A Kattan; Mohamed F Alotaibi; Hassan M Alzahrani; Waleed M Altaweel
Journal:  J Kidney Cancer VHL       Date:  2017-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.